Search

everythinglearnresearchcommunity

for

Search:↓

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Lower LDL-c levels predict higher COVID-19 mortality.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

Platelet-rich plasma (PRP) significantly improves long-lasting post-viral smell dysfunction.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Physical activity increased, but sedentary behavior also rose, especially in men.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Baricitinib may effectively treat oral lichen planus.

Minoxidil and Finasteride are the most popular hair loss treatments, with rising interest in other options, and economic or health crises can change what treatments people prefer.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

EH-MSCs may help treat hair loss by reducing inflammation.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Photobiomodulation therapy shows promise in treating various health conditions by using specific light wavelengths.

The mesenchymal stem cell secretome may effectively treat various diseases as an alternative to traditional stem cell therapies.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

Vaccinated healthcare workers rarely experience long COVID-19 symptoms.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Long COVID is a big health problem needing more research and better treatments.

Long COVID sufferers face significant challenges that need more public awareness and support.

Vaccination and timely treatment reduce the risk of long COVID.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.